CONMED Corp. buy Piper Sandler
Start price
27.10.23
/
50%
€89.00
Target price
27.10.24
€123.12
Performance (%)
-34.83%
End price
28.10.24
€58.00
Summary
This prediction ended on 28.10.24 with a price of €58.00. Massive losses of -34.83% were the result for the BUY prediction by Piper_Sandler. Piper_Sandler has a follow-up prediction for CONMED Corp. where he still thinks CONMED Corp. is a Buy. Dividends of €0.73 are taken into consideration when calculating the performance. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CONMED Corp. | 0.000% | 0.000% | -50.519% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Piper_Sandler for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $145.00 to $130.00. They now have an "overweight" rating on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten

